new glp 1 drug How GLP-1 medications are transforming diabetes and weight loss treatment New GLP-1 weight-loss drugs are

These medications are one tool, says Kumar

Helmstadter, J

While more research is needed in this area, a study looking at GLP1 receptor agonist use and opioid overdose risk in patients with type 2 diabetes and opioid use disorder (OUD) found that semaglutide was associated with reduced opioid overdose risk in patients with comorbid T2D and OUD

Amylase, lipase, and acute pancreatitis in people with type 2 diabetes treated with liraglutide: results from the LEADER randomized trial

Recent preclinical data have illuminated additional molecular pathways underlying SGLT2 inhibitor-induced kidney protection

N Engl J Med 2021;385:50315.ArticlePubMed 54